Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal
Shares of Acelyrin, Inc. (NASDAQ: SLRN) increased 12.44% to $2.44 on Thursday after an equity-related development was confirmed. An unsolicited takeover offer from Concentra Biosciences, LLC, a business owned by Tang Capital Partners, LP, was the catalyst for the spike. Buyout Interest In addition to offering shareholders a contingent value right (CVR) that would entitle …
Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal Read More »